Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

BRIEF-Apricus Biosciences expands existing partnership with Fe...

July 25 Apricus Biosciences * Apricus biosciences inc says apricus and sandoz agree to mutually terminate license agreement * Apricus eligible to receive additional $3.6 million in upfront and pre-commercialization milestone payments for ... Reuters UK, 4 days ago

3 images for "sandoz inc"

Money Control, 5 months ago
India Infoline, 5 months ago
Business Standard, 5 months ago

AstraZeneca Resolves Faslodex Patent Litigation in US

By Razak Musah Baba LONDON--AstraZeneca PLC (AZN.LN) has entered an agreement with Sandoz, Inc. and affiliates to resolve a U.S. patent litigation relating to its hormonal therapy drug Faslodex, the British pharmaceutical giant said Wednesday. ...
 Morningstar.com2 weeks ago AstraZeneca Enters Into Deal To Resolve Faslodex Patent Litigation In US  Pharmacy Choice2 weeks ago ASTRAZENECA : Resolves Faslodex Patent Litigation in US  4 Traders2 weeks ago ASTRAZENECA : AZ resolves Faslodex patent litigation in the US  4 Traders2 weeks ago

Federal Circuit Confirms That the BPCIA Always Requires Post-Licensure Notice

The Federal Circuit answered one of the questions left open by its July 27, 2015, decision in Amgen Inc. v. Sandoz Inc. (Appeal No. 2015-1499): whether the 180-day commercial marketing notice under the Biologics Price Competition and Innovation Act ...
 JD Supra3 weeks ago New Guidance on Mandatory Notice in the Biosimilar Patent Dance  JD Supra2 weeks ago Biosimilars: 180-day notice is mandatory  Intellectual Asset Management2 weeks ago Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory  National Law Review3 weeks ago
Bidness Etc

Will Amgen, Inc. Surprise Investors this Quarter?

Amgen, Inc. ( NASDAQ:AMGN ) is slated to report its second quarter earnings today after markets close. Analysts expect only a slight yearly increase in revenue, as generic competition has taken its toll on some of its blockbuster drugs. What ...
 Bidness Etc1 day ago AbbVie Inc: FDA May Favor Early Entry for Humira Biosimilar  Bidness Etc2 weeks ago Amgen, Inc. Poses Real Threat to AbbVie Inc Humira  Bidness Etc2 weeks ago Stiff Biosimilar Headwinds To Negatively Impact Amgen's Aging Drug Portfolio  Benzinga.com1 month ago

Versartis' Long-Acting Somavartan Could Replace Current Treatments In Growth Hormone Deficiency

Jul.28.16 | About: Versartis, Inc. (VSAR) Follow Registered investment advisor, hedge fund manager, research analyst, biotech | Summary Versartis, Inc. (NASDAQ: VSAR) is developing a long-acting (once or twice monthly) formulation of ...
 Seeking Alpha1 day ago
Bidness Etc

AbbVie Inc Wins 10th US Approval for Humira

AbbVie Inc. ( NYSE:ABBV ) won yet another label expansion for its anti-inflammatory megablockbuster drug Humira in the US on Friday. The drug can now be used for the treatment of non-infectious intermediate, posterior and panuveitis in adults. This ...
 Bidness Etc3 weeks ago AbbVie Inc Pipeline May Not Compensate for Humira's Loss  Bidness Etc1 month ago Abbvie: Home Cooking Is Hard To Beat  Seeking Alpha4 weeks ago

BRIEF-Spectrum Pharmaceuticals unit, Allos Therapeutics and Sandoz enter settlement agreement

June 9 Spectrum Pharmaceuticals Inc : * On June 8, 2016, co's unit , Allos Therapeutics and Sandoz Inc entered into a settlement agreement * Spectrum Pharmaceuticals Inc says settlement agreement to resolve patent litigation relating to ...
 Reuters UK1 month ago Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement  Reuters UK1 month ago

Dr. Bassam Damaj Appointed to Hispanica International Delights of America, Inc. Board of Directors

- Hispanica International Delights of America, Inc. (OTC PINK: HISP), a diversified food and beverage company in the Hispanic and ethnic food industry, announced today the appointment of Bassam Damaj, PhD to its Board of Directors. Dr. Damaj brings ...
 4 Traders2 weeks ago

FDA panel supports Novartis version of Amgen arthritis drug

Novartis AG's cheaper version of Amgen Inc's arthritis drug Enbrel is highly similar in potency and safety to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The panel voted ...
 Pharmaceutical Tech.com2 weeks ago FDA: Novartis Arthritis Drug 'Highly Similar' to Amgen's Enbrel  Pharmaceutical Manufacturing Magazine2 weeks ago Novartis copy of Amgen arthritis drug highly similar: FDA staff  Pharma Focus Asia2 weeks ago U.S. FDA panel supports Novartis version of Amgen arthritis drug  Sharenet2 weeks ago

Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan

Amgen Inc. AMGN announced an exclusive agreement with Daiichi Sankyo Company, Limited for the commercialization of nine biosimilars in Japan including biosimilars of AbbVie's ABBV Humira and Roche Holding AG's RHHBY Avastin and Herceptin. The ...
 Yahoo! Singapore2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less